Building out in obesity biocentury.com To view or add a comment, sign in Business News: ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes - Fierce Biotech: * ADA: Lilly pulls back curtain on impressive triple-G efficacy in patients with obesity, diabetes Fierce Biotech * Triple-action diabetes jab shown to reduce blood sugar and body weight The Guardian * Eli Lilly Shares Rise Premarket on Late-Stage Weight Loss Trial Success WSJ * Retatrutide Data Show Dramatic Weight Loss, Other Benefits Medscape * Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits Reuters #Diabetes #Obesity #WeightLoss #EliLilly #Pharmaceuticals To view or add a comment, sign in Exciting new clinical finding for GLP-1 receptor agonists, just published in JAMA Network Open
10.3390/nu16111545 225 KangJ.-E.LimM
Also, soreness can feel worse
Insulin controls blood sugar after meals
Anything that is severe, worsening, or systemic is a reason to stop and seek a clinician rather than to adjust the protocol
Rapid blood-sugar changes from starting Ozempic can temporarily affect vision, so diabetic patients should have regular eye monitoring while on the medication
